Supplementary Table S1 from A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism
Abstract
Supplementary Table S1: Sequence of TJH2201 (hz145A2/hz176G1)
Fields of Study & Subjects
Phagocytosis and Immune Regulation
Chemokine receptors and signaling
Erythrocyte Function and Pathophysiology
Publication details
- Publication date
- 2 January 2026